ASH Annual Meeting

Tim H. Brummendorf, MD¹, Carlo Gambacorti-Passerini, MD², Andreas Hochhaus, MD³, Jeff H. Lipton, MD, PhD⁴, Vamsi Kota, MBBS⁵, Michael W. Deininger, MD, PhD⁶, Eric Leip, PhD^7*, Andrea Viqueira, MD^8*, Roxanne Ferdinand, MBBS MFPM^9* and Jorge E. Cortes, MD¹⁰

¹Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, Universitätsklinikum RWTH Aachen, Aachen, Germany
²School of Medicine and Surgery, University of Milano Bicocca, Monza, MB, Italy
³Klinik für Innere Medizin II, Abt. Hämatologie und Internistische Onkologie, Universitätsklinikum Jena, Jena, Germany
⁴Blood and Marrow Transplant Program, Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
⁵Winship Cancer Instiute of Emory University, Atlanta, GA
⁶Division of Hematology and Hematologic Malignancies, University of Utah, Salt Lake City, UT
⁷Pfizer Inc, Cambridge, MA
⁸Pfizer SLU, Madrid, Spain
⁹Pfizer Ltd, Walton-on-the-Hill, United Kingdom
¹⁰Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

Giovanni Caocci, MD^1*, Olga Mulas^2*, Elisabetta Abruzzese³, Alessandra Iurlo^4,5*, Imma Attolico, MD^6*, Sara Galimberti^7*, Luigia Luciano, MD⁸, Nicola Sgherza, MD^9*, Massimiliano Bonifacio^10*, Mario Annunziata^11*, Antonella Gozzini, MD^12*, Ester Maria Orlandi, MD^13*, Fabio Stagno, MD, PhD¹⁴, Gianni Binotto, MD^15*, Claudio Fozza, MD^16*, Malgorzata Monika Trawinska, MD^17*, Daniele Cattaneo, MD^5*, Francesco Albano, MD^18*, Claudia Baratè, MD, PhD^19*, Fiorenza De Gregorio, MD^8*, Luigi Scaffidi, MD^20*, Chiara Elena, MD^21*, Matteo Molica, MD^22*, Giorgio La Nasa, MD^2*, Robin Foà, MD²³ and Massimo Breccia, MD^24*

¹Department of Medical Sciences and Public Health, University of Cagliari, "A.Businco" Hospital, Cagliari, Italy
²Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy
³Hematology, S.Eugenio Hospital, Roma, Italy
⁴Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy
⁵Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
⁶University of Bari, Bari, Italy
⁷Hematology Department, University of Pisa, Pisa, Italy
⁸Hematology - Department of Clinical Medicine and Surgery, Federico II University, Napoli, Italy
⁹Division of Hematology, IRCCS Ospedale Casa Sollievo Sofferenza, San Giovanni Rotondo, Italy
¹⁰Department of Medicine, Section of Haematology, Verona University, Verona, Italy
¹¹Hematology, Ospedale Cardarelli, Napoli, Italy
¹²SC Terapie Cellulari e Medicina Trasfusionale, AOU Careggi, Florence, Italy
¹³Hematology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
¹⁴Hematology Unit, Hematology Section, Biomedical Sciences, Trecastagni, Catania, Italy
¹⁵Hematology and Clinical Immunology, Department of Medicine, Padua School of Medicine, Padova, Italy
¹⁶Department of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy
¹⁷Tor Vergata University, Hematology, S. Eugenio Hospital, Roma, ITA
¹⁸University of Bari, Department of Emergency and Organ Transplantation (D.E.T.O.), Hematology Section, Bari, Italy
¹⁹Department of Clinical and Experimental Medicine, Section of hematology, University of Pisa, Pisa, Italy
²⁰Department of Medicine, Section of Hematology, Department of Hematology, University of Verona, Verona, Italy
²¹Department of Hematology Oncology, Foundation IRCCS Policlinico San Matteo, Pavia, Italy
²²Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy
²³Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University of Rome, Policlinico Umberto I, Rome, Italy
²⁴Division of Cellular Biotechnologies and Hematology, University "Sapienza", Roma, Italy

Simone Claudiani, MD^1,2*, Jane Apperley, MB ChB MD^1,3, Afzal Khan^2*, Richard Szydlo, PhD^2*, George Nesr, MD^1,2*, George Adams, MBChB^1,2*, Letizia Foroni, MD, PhD^4*, Jamshid S Khorashad, MD, PhD^2,5* and Dragana Milojkovic, MBBS, PhD^1*

¹Department of Haematology, Hammersmith Hospital (Imperial College Healthcare NHS Trust), London, United Kingdom
²Centre for Haematology, Department of Medicine, Imperial College London, London, United Kingdom
³Centre for Haematology, Imperial College London, London, United Kingdom
⁴Centre for Haematology, Imperial College London at Hammersmith Hospital, London, United Kingdom
⁵Molecular Diagnostics, Imperial College Healthcare NHS Trust, London, United Kingdom

Hiroyuki Shimada, MD, PhD^1*, Akihiko Tanizawa, MD, PhD^2*, Takeshi Kondo, MD, PhD³, Hideki Muramatsu, MD, PhD⁴, Masahiro Yasui, MD⁵, Arinobu Tojo, MD, PhD⁶, Tokiko Nagamura-Inoue, MD, PhD⁷, Tetsuya Eto, MD, PhD^8*, Aiko Igarashi, MD^9*, Heiwa Kanamori, MD, PhD¹⁰, Maho Sato, MD^5*, Maiko Noguchi, MD^11*, Tatsuo Ichinohe, MD, PhD¹², Masami Inoue, MD⁵, Koji Kato, MD, PhD^13*, Yoshiko Atsuta, MD, PhD^14* and Kazuteru Ohashi, MD, PhD^9*

¹Department of Pediatrics, Keio University School of Medicine, Tokyo, Japan
²Department of Human Resource Development for Cancer, Faculty of Medical Sciences, University of Fukui, Fukui, Japan
³Department of Hematology, Aiiku Hospital, Sapporo, Japan
⁴Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan
⁵Department of Hematology/Oncology, Osaka Women's and Children's Hospital, Osaka, Japan
⁶Division of Molecular Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
⁷Department of Cell Processing and Transfusion, IMSUT Cell Resource Center, Research Hospital,The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
⁸Department of Hematology, Hamanomachi Hospital, Fukuoka, Japan
⁹Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan
¹⁰Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan
¹¹Department of Pediatrics, National Kyushu Cancer Center, Fukuoka, Japan
¹²Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan
¹³Department of Hematology and Oncology, Children’s Medical Center, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan
¹⁴The Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan

Abhishek Maiti, MBBS^1,2, Hagop M. Kantarjian, MD³, Elias J. Jabbour, MD², Rebecca Poku, MPH^2*, Brittany A Yearby^2*, Stephanie Breakefield, RN^2*, Farhad Ravandi, MBBS² and Jorge E. Cortes, MD²

¹Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, TX

Jieun Uhm, MD, PhD¹, Sung-Hyun Kim, MD, PhD², Sukjoong Oh, MD, PhD³, Dae Young Zang, MD, PhD^4*, Young Rok Do, PhD, MD⁵, Won Sik Lee, MD, PhD⁶, Myung Hee Chang, MD^7*, Sung-Eun Lee, MD, PhD^8* and Dong-Wook Kim, MD, PhD^9,10

¹Division of Hematology and Oncology, Department of Internal Medicine, Hanyang University Seoul Hospital, Hanyang University College of Medicine, Seoul, Korea, Republic of (South)
²Department of Internal Medicine, Dong-A University College of Medicine, Dong-A University Hospital, Busan, Korea, Republic of (South)
³Division of Hematology-Oncology, Kangbuk Samsung Hospital, Sungkyunkwan University, Seoul, Korea, Republic of (South)
⁴Department of Internal Medicine, Hallym University College of Medicine, Hallym University Sacred Heart Hospital, Anyang-Si, Korea, Republic of (South)
⁵Department of Internal Medicine, Dongsan Medical Center Keimyung University, Daegu, Korea, Republic of (South)
⁶Department of Internal Medicine, Inje University Busan Paik Hospital, Busan, Korea, Republic of (South)
⁷National Health Insurance Corp. Ilsan Hospital, Koyang, KOR
⁸Department of Hematology, Catholic Hematology Hospital, Seoul, Korea, Republic of (South)
⁹Leukemia Research Institute, The Catholic University of Korea, Seoul, Korea, Republic of (South)
¹⁰Department of Hematology, Seoul St. Mary's Hospital The Catholic University of Korea, Seoul, South Korea

Lucia Masarova, MD^1*, Jorge E. Cortes, MD^1*, Keyur P. Patel, MBBS, PhD², Susan M. O'Brien, MD³, Graciela M. Nogueras González, MPH^4*, Marina Y. Konopleva, MD, PhD⁵, Srdan Verstovsek, MD, PhD¹, Guillermo Garcia-Manero, MD⁶, Alessandra Ferrajoli, MD⁷, Tapan M. Kadia, MD⁸, Farhad Ravandi, MBBS¹, Gautam Borthakur, MD¹, Sara Emogene Dellasala, BS^9*, Elias J. Jabbour, MD ¹⁰ and Hagop M. Kantarjian, MD⁶

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Hematopathology, University of Texas M.D. Anderson Cancer Center, Houston, TX
³UC Irvine, Chao Family Comprehensive Cancer Center, Orange, CA
⁴Biostatistics, UT MD Anderson Cancer Center, Houston
⁵Department of Leukemia, MD Anderson Cancer Center, Houston, TX
⁶Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, TX
⁷Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
⁸Department of Leukemia, M.D. Anderson Cancer Center, Houston, TX
⁹UT MD Anderson Cancer Center, Houston, TX
¹⁰Deparmt, The University of Texas MD Anderson Cancer Center, Houston, TX

Simona Bernardi, PhD^1,2*, Michele Malagola, MD³, Camilla Zanaglio, PhD^1*, Alessandra Iurlo^4*, Cristina Bucelli, MD^5*, Nicola Polverelli, MD^1*, Elif Dereli Eke, PhD Student^6,7*, Massimiliano Bonifacio^8*, Eleonora Toffoletti^9*, Mario Tiribelli^10*, Clara Deambrogi, PhD^11*, Gianluca Gaidano, MD, PhD¹¹, Stefania Stella, PhD^12*, Fabio Stagno, MD, PhD¹³, Paolo Vigneri, MD, PhD^14*, Francesco Di Raimondo, MD^15*, Mirko Farina, MD^1,16*, Mariella D'Adda^16*, Doriana Gramegna, MD^16*, Elisa Cerqui, MD^16*, Giuseppe Rossi, MD¹⁶, Micaela Bergamaschi, MD^17*, Marco Gobbi, MD^18*, Luca Franceschini, M.D., PhD^19*, Maria Teresa Voso¹⁹, Elisabetta Abruzzese²⁰, Malgorzata Monika Trawinska, MD^21* and Domenico Russo, MD¹

¹Bone Marrow Transplant Unit, ASST-Spedali Civili di Brescia, Chair of Hematology, Dpt of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy
²Laboratorio CREA (Centro di Ricerca Emato-oncologica AIL), ASST Spedali Civili of Brescia, Brescia, Italy
³Cattedra di Ematologia, USD-TMO, University of Brescia-ASST Spedali Civili of Brescia, Brescia, ITA
⁴Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
⁵Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, and University of Milan, Milano, Italy
⁶Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy
⁷CREA Lab, Spedali Civili of Brescia, Brescia, Italy
⁸Department of Medicine, Section of Haematology, Verona University, Verona, Italy
⁹Division of Hematology and BMT, Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy
¹⁰Division of Hematology and BMT, Department of Medical Area, University of Udine, Udine, Italy
¹¹Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy
¹²Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy
¹³Chair and Hematology Section, Ferrarotto Hospital, Catania, Italy
¹⁴Dep. Clinical and Experimental Medicine, University of Catania Medical School, Catania, Italy
¹⁵Divisione di Ematologia, Ospedale Ferrarotto, A.O.U. Policlinico-OVE, Università di Catania, Catania, Italy
¹⁶Department of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy
¹⁷Division of Hematology, University of Genoa, Opsedale policlinico San Martino, IRCCS per l'Oncologia, Dipartment of Internal Medicine, Genova, Italy
¹⁸Clinic of Hematology, Department of Internal Medicine (DiMI), IRCCS Ospedale Policlinico San Martino, Genova, Italy
¹⁹Department of Biomedicine and Prevention, University Tor Vergata, Rome, Italy
²⁰Hematology, S.Eugenio Hospital, Roma, Italy
²¹Tor Vergata University, Hematology, S. Eugenio Hospital, Roma, ITA

Mahesh Swaminathan, MD^1*, Hagop M. Kantarjian, MD¹, Koji Sasaki, MD¹, Farhad Ravandi, MBBS², Gautam Borthakur, MD¹, Tapan M. Kadia, MD³, Guillermo Garcia-Manero, MD⁴, Courtney D. DiNardo, MD, MSc⁵, Marina Y. Konopleva, MD, PhD⁶, Zeev E. Estrov, MD¹, Naveen Pemmaraju, MD¹, Naval G. Daver, MD⁶, William G. Wierda, MD, PhD¹, Alessandra Ferrajoli, MD⁷, Sherry A. Pierce, BSN, BA^1*, MD Emogene Dellasala, BS^8*, Elias J. Jabbour, MD ¹ and Jorge E. Cortes, MD^1*

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Leukemia, University of Texas- MD Anderson Cancer Center, Houston, TX
³Department of Leukemia, M.D. Anderson Cancer Center, Houston, TX
⁴Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, TX
⁵Department of Leukemia, UT MD Anderson Cancer Center, Houston, TX
⁶Department of Leukemia, MD Anderson Cancer Center, Houston, TX
⁷Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
⁸Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston

Franck Emmanuel Nicolini, MD, PhD^1,2,3, Vincent Alcazer, MD^2*, Pascale Cony-Makhoul, MD, PhD^3,4*, Stephanie Dulucq, PhD^3,5*, Sandrine Hayette, PhD^3,6*, Isabelle Tigaud, MD^6*, Liliana Villa, MD^7*, Mohamad Sobh, PharmD^2*, Stephane Morisset, Stat^2*, Francois-Xavier Mahon, MD, PhD^3,8 and Gabriel Etienne, MD, PhD^3,9*

¹INSERM U590, CRCL, Lyon, France
²Hematology, Centre Leon Berard, Lyon, France
³French group of CML (Fi-LMC), Pessac, France
⁴Centre Hospitalier Annecy-Genevois, Pringy, France
⁵Laboratory of Hematology, Hopital Haut Leveque, Pessac, France
⁶Laboratory of Hematology and molecular biology, CHU Lyon Sud, Pierre Benite, France
⁷Laboratory of Hematology, Groupement Hospitalier Est, Bron, France
⁸Hematology Department, Institut Bergonie, Bordeaux, France
⁹Hematology Department, Institut Bergonié, Bordeaux, France

Stephanie Foulon, MD^1,2,3*, Pascale Cony-Makhoul, MD, PhD^4*, Agnes Guerci-Bresler, MD, PhD^5*, Marc Delord, PhD^6*, Eric Solary, MD, PhD⁷, Alain Monnereau, MD, PhD^8*, Julia Bonastre, PhD^1,2* and Pascale Tubert Bitter, PhD^3*

¹Biostatistics Department, Gustave Roussy, Villejuif, France
²CESP Centre for Research in Epidemiology and Population Health, INSERM U1018, Paris-Sud Univ., Villejuif, France
³B2PHI Biostatistics, Biomathematics, Pharmacoepidemiology and Infectious Diseases, Inserm U1181, UVSQ, Institut Pasteur, Université Paris-Saclay, Villejuif, France
⁴Centre Hospitalier Annecy-Genevois, Pringy, France
⁵Service Hématologie, CHRU Brabois, Vandoeuvre, France
⁶Institut Universitaire d'Hématologie, Université Paris 7, Hôpital Saint Louis, Paris, France
⁷Department of Hematology, Gustave Roussy Cancer Center, Villejuif, France
⁸Registre des hémopathies malignes de la Gironde, Centre de Lutte Contre le Cancer, F-33076, Bordeaux, Réseau REPIH, Bordeaux, France

Tatsuro Jo, MD, PhD, Yohei Kaneko^*, Kazuhiro Noguchi^*, Shizuka Hayashi^*, Risa Hayase^*, Haruna Shioya^*, Sadaharu Irie^*, Kensuke Horio, MD^* and Jun Taguchi, MD, PhD^*

Japanese Red Cross Nagasaki Genbaku Hospital, Nagasaki, Japan

Dong-Wook Kim, MD, PhD^1,2, Sung-Eun Lee, MD, PhD^3*, Soo Young Choi^4*, Dae Young Zang, MD, PhD^5*, Won-Sik Lee⁶, Yeung-Chul Mun^7*, Young Rok Do, PhD, MD⁸ and Sukjoong Oh, MD, PhD⁹

¹Department of Hematology, Seoul St. Mary's Hospital The Catholic University of Korea, Seoul, South Korea
²Leukemia Research Institute, The Catholic University of Korea, Seoul, Korea, Republic of (South)
³Department of Hematology, Leukemia Research Institute, Seoul St. Mary’s Hematology Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
⁴Leukemia Research Institute, The Catholic University of Korea, Seoul, South Korea
⁵Department of Internal Medicine, Hallym University College of Medicine, Hallym University Hospital, Anyang, Korea, Republic of (South)
⁶Department of Internal Medicine,, Inje University College of Medicine, Busan Paik Hospital, Busan, Korea, Republic of (South)
⁷Department of Hematology, Ewha Womans University, Seoul, Korea, Republic of (South)
⁸Department of Internal Medicine, Dongsan Medical Center Keimyung University, Daegu, Korea, Republic of (South)
⁹Division of Hematology-Oncology, Kangbuk Samsung Hospital, Seoul, Korea, Republic of (South)

Carole Maute^1*, Audrey Gauthier^2*, Gwo-Jen Day, PhD^3* and Jean-Michel Cayuela, PhD^2,4*

¹Laboratory of Hematology, University Hospital Saint-Louis, AP-HP, Paris & GBMHM External Quality Assessment platform, Pairs, France
²Laboratory of Hematology, University Hospital Saint-Louis, AP-HP, Paris & GBMHM External Quality Assessment platform, Paris, France
³Oncology R&D, Cepheid, Sunnyvale, CA
⁴EA 3518, University Paris 7, Paris, France

Hwang Wen-Li, MD^1,2*, Shao-Min Han, MD^1*, Shyuann-Yuh Lin, MD^3*, Ming-Chih Chang, MD^4*, Li-Yuan Bai, PhD^5*, Pei-Ching Hsiao, MD^6*, Ching-Yuan Kuo^7*, Yeu-Chin Chen, MD^8*, Ta-Chih Liu, MD, PhD^9*, Po-Nan Wang, MD¹⁰, Jyh-Pyng Gau, MD^11*, Yee-Ming Lee, PhD^12*, Fan-Chen Ku^12* and Jih-Luh Tang, MD¹³

¹Taichung Veterans General Hospital, Taichung, Taiwan
²Asian University Hospital, Taichung, Taiwan
³Changhua Christian Hospital, Changhua, Taiwan
⁴MacKay Memorial Hospital, Taipei City, Taiwan
⁵Division of Hematology and Oncology, China Medical University Hospital, Taichung, Taiwan
⁶Chung Shan Medical University Hospital, Taichung, Taiwan
⁷Division of Hematology/Oncology, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City, Taiwan
⁸Tri-Service General Hospital (TSGH), Taipei, Taiwan
⁹Kaohsiung Medical Univ. Hospital, Kaohsiung, Taiwan
¹⁰Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan
¹¹Division of Hematology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
¹²Novartis (Taiwan) Co. Ltd., Taipei, Taiwan
¹³Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan

Hawk Kim, MD, PhD¹, Yunsuk Choi, MD^2*, Sung-Soo Yoon, MD, PhD³, Won-Sik Lee⁴, Jee Hyun Kong, MD^5*, Kyoo-Hyung Lee, MD, PhD^6*, Jeong-Yeal Ahn, MD^7* and Sang Kyun Sohn, MD, PhD^8*

¹Division of Hematology, Gachon University Gil Medical Center, Incheon, Korea, Republic of (South)
²Department of Hematology, University of Ulsan College of Medicine, Ulsan University Hospital, Ulsan, Korea, Republic of (South)
³Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea, Republic of (South)
⁴Department of Internal Medicine,, Inje University College of Medicine, Busan Paik Hospital, Busan, Korea, Republic of (South)
⁵Division of Hematology-oncology, Department of Internal Medicine, Wonju Severance Christian Hospital, Yonsei University College of Medicine, Wonju, Korea, Republic of (South)
⁶Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
⁷Department of Laboratory Medicine, Gachon University Gil Medical Center, Incheon, Korea, Republic of (South)
⁸Department of Hematology–Oncology, Kyungpook National University Hospital, Daegu, Korea, Republic of (South)

Imma Attolico, MD^1*, Roberto Latagliata^2*, Massimo Breccia, MD^3*, Elisabetta Abruzzese⁴, Alessandra Iurlo^5*, Isabella Capodanno, MD^6*, Mario Annunziata^7*, Sara Galimberti^8*, Mario Tiribelli^9*, Bruno Martino, MD^10*, Antonella Gozzini^11*, Anna Rita Scortechini, MD^12*, Chiara Elena, MD^13*, Fausto Castagnetti¹⁴, Luigia Luciano, MD¹⁵, Carmen Fava¹⁶, Patrizia Pregno^17*, Fabio Stagno, MD, PhD¹⁸, Micaela Bergamaschi, MD^19*, Gianni Binotto, MD^20*, Massimiliano Bonifacio^21*, Giovanni Caocci, MD^22*, Monica Crugnola, MD^23*, Francesco Tarantini^1*, Giorgina Specchia, MD¹ and Francesco Albano, MD^1*

¹University of Bari, Department of Emergency and Organ Transplantation (D.E.T.O.), Hematology Section, Bari, Italy
²Department of Biotechnologies and cellular Hematology, Sapienza Università, Rome, Italy
³Division of Cellular Biotechnologies and Hematology, University "Sapienza", Roma, Italy
⁴Hematology Unit, S. Eugenio Hospital, Roma, Italy
⁵Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
⁶Azienda Unità Sanitaria Locale-IRCCS, Hematology Unit, Reggio Emilia, Italy
⁷Hematology, Ospedale Cardarelli, Napoli, Italy
⁸Hematology Department, University of Pisa, Pisa, Italy
⁹Division of Hematology and BMT, Department of Medical Area, University of Udine, Udine, Italy
¹⁰Haematology Dept.- Azienda Ospedaliera Bianchi Melacrino Morelli, Reggio Calabria, Italy
¹¹Divisione di Ematologia-Policlinico Careggi di Firenze, Firenze, ITA
¹²Hematology Unit, A.O.U. Ospedali Riuniti, Ancona, Italy
¹³Department of Hematology Oncology, Foundation IRCCS Policlinico San Matteo, Pavia, Italy
¹⁴Institute of Hematology "L. e A. Seràgnoli", DIMES, University of Bologna, Bologna, Italy
¹⁵Hematology - Department of Clinical Medicine and Surgery, Federico II University, Napoli, Italy
¹⁶Department of Clinical and Biological Science, University of Turin, Orbassano, Italy
¹⁷Hematology Unit, Az Ospedaliero Universitaria Città' della Salute e della Scienza, Torino, Italy
¹⁸Chair and Hematology Section, Ferrarotto Hospital, Catania, Italy
¹⁹Hematology Clinic, Policlinico San Martino-IST, Genova, Italy
²⁰Hematology and Clinical Immunology, Department of Medicine, Padua School of Medicine, Padova, Italy
²¹Department of Medicine, Section of Haematology, Verona University, Verona, Italy
²²Department of Medical Sciences and Public Health, University of Cagliari, "A.Businco" Hospital, Cagliari, Italy
²³Department of Medicine and Surgery, University of Parma, Parma, Italy

Aisling Nee, MB, Jeffrey H. Lipton, MD, PhD and Dennis Dong Hwan Kim, MD

Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada

Anna Petrova, MD^1*, Ekaterina Chelysheva, MD, PhD^2*, Oleg Shukhov, MD, PhD^2*, Anastasiya Bykova, MD^2*, Galina Gusarova, MD, PhD^2*, Irina Nemchenko, MD, PhD^2*, Nikolay Tsyba, MD, PhD^2*, Anna G Turkina, Prof., MD², Tatiana Nikitina, PhD^3,4*, Natalia Porfirieva^3*, Anna Zinkovskaya^3* and Tatiana Ionova, DSc^4,5*

¹National Research Center for Hematology, Moscow, Russia
²National Research Center for Hematology, Moscow, Russian Federation
³Multinational Center for Quality of Life Research, Saint-Petersburg, Russian Federation
⁴Clinic of High Medical Technologies named after N.I. Pirogov, Saint-Petersburg, Russian Federation
⁵University Clinic, St. Petersburg State University and Multinational Center for Quality of Life Research, Saint-Petersburg, Russian Federation

Frederic Picou, PhD^1*, Jean-Claude Chomel, PharmD PhD^2*, Marie Christine Bene, PharmD^3*, Marc G. Berger, MD, PhD^4,5*, Thierry Fest^6*, Valerie Ugo, MD, PhD⁷, Eric Lippert, MD, PhD^8*, Marion Socco-Luca^9*, Martine Delain, MD^10*, Marie-Helene Estienne, PharmD^9* and Olivier Herault, MD, PhD¹¹

¹CNRS ERL 7001 LNOx "Leukemic Niche & Redox Metabolism", Tours, France
²Department of Biological Cancerology, University Hospital of Poitiers, Poitiers, France
³Department of Biological Hematology, University Hospital of Nantes, Nantes, France
⁴Department of Biological Hematology, University Hospital of Clermont-Ferrand, Clermont-Ferrand, France
⁵EA 7453 CHELTER, Clermont-Ferrand, France
⁶Department of Biological Hematology, University Hospital of Rennes, Rennes, France
⁷Laboratory of Hematology, University Hospital of Angers, Angers, France
⁸Department of Biological Hematology, University Hospital of Brest, Brest, France
⁹Department of Biological Hematology, University Hospital of Tours, Tours, France
¹⁰Department of Hematology and Cellular Therapy, University Hospital of Tours, Tours, France
¹¹Dept of Biological Hematology, University Hospital of Tours, Tours, France

Aytug Kizilors, PhD^1,2*, Patrick Harrington, FRCPath, MRCP^2,3*, Sophie Jackson, BSc^2*, Nicholas Lea, PhD^4*, Joel Newman, MBBS, MRCP, BSc, FRCPath^5*, Richard Gale, FRCPath, FRCP^6*, Sandra Hassan, MD^7*, Evangelia Dimitriadou, MD^8*, Elena Crisà, MD^9*, Luke Ficinski, BSc^2*, Isabel Sa, BSc^2*, Anita Arasaretnam, MD^10*, Vijayavalli Dhanapal, MD^11*, Timothy Corbett, FRCP, FRCPath^10*, Robin M. Ireland, FRCP¹², Antonio Pagliuca^13,14, Ghulam J. Mufti^12,15* and Hugues De Lavallade^16,17*

¹Haematology, Kings College London, LONDON, United Kingdom
²Haematology, King's College Hospital NHS Foundation Trust, London, United Kingdom
³King's College London, London, GBR
⁴King's College Hospital NHS Foundation Trust, London, GBR
⁵East Sussex Healthcare NHS Trust, Haematology, Eastbourne District General Hospital, Eastbourne, United Kingdom
⁶The Tunbridge Wells Hospital At Pembury, Tunbridge Wells, GBR
⁷Department of Haematology, Queen's Hospital, Romford, United Kingdom
⁸Haematology department, Maidstone Hospital, Maidstone, United Kingdom
⁹Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy
¹⁰Haematology, Brighton and Sussex University Hospitals NHS Trust, Brighton, United Kingdom
¹¹Haematology, Medway Maritime Hospital, Gilligham, United Kingdom
¹²Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, United Kingdom
¹³King's College Hospital, London, United Kingdom
¹⁴King’s College London, Molecular Haematology, Division of Cancer Studies, London, United Kingdom
¹⁵Department of Haemato-Oncology, King's College London, London, United Kingdom
¹⁶Department of Haematological Medicine, Kings College Hospital NHS Foundation Trust, London, United Kingdom
¹⁷Haematology department, King's College London, London, United Kingdom

Koji Sasaki, MD¹, Hagop M. Kantarjian, MD², Farhad Ravandi, MBBS¹, Marina Y. Konopleva, MD, PhD¹, Gautam Borthakur, MD¹, Guillermo Garcia-Manero, MD², William G. Wierda, MD, PhD², Naval G. Daver, MD¹, Alessandra Ferrajoli, MD¹, Koichi Takahashi, MD³, Guillermo Montalban-Bravo, MD^2*, Mary B. Rios, RN^4*, Sherry A. Pierce, BSN, BA^1*, Kenichi Sakurai, MD^1*, Elias J. Jabbour, MD¹ and Jorge E. Cortes, MD¹

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, TX
³Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
⁴Deaprtment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX